Danielle M. Lussier

Medicine · Health Sciences

7h-index2.1kcitations20works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(14), Immunotherapy and Immune Responses(13), CAR-T cell therapy research(10), Immune cells in cancer(3), Diet and metabolism studies(3)

Publications20 total

The Ethical Imperative
Canadian Military Journal·2023Open Access
Identifying Key Differences Between Responders vs. Non-Responders to Immune Checkpoint Blockade for Metastatic Osteosarcoma (mOS)
The Journal of Immunology·2022
Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads
Proceedings of the National Academy of Sciences·2021· 123 citedOpen Access
MHC-II neoantigens shape tumour immunity and response to immunotherapy
Nature·2019· 837 citedOpen Access
MHC-II neoantigens shape tumour immunity and response to immunotherapy
RePEc: Research Papers in Economics·2019
Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity
Cold Spring Harbor Perspectives in Biology·2018· 537 citedOpen Access
Immune Checkpoint Blockade: Subjugation of the Masses
InTech eBooks·2017Open Access
Progress and Opportunities for Immune Therapeutics in Osteosarcoma
Immunotherapy·2016· 60 cited
Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet
BMC Cancer·2016· 152 citedOpen Access
Cancer Immunosurveillance: Immunoediting
Elsevier eBooks·2016
Cancer Immunosurveillance: Immunoediting
Elsevier eBooks·2016· 5 cited
Abstract B73: Ketogenic diet enhances immunity to glioblastoma
Cancer Immunology Research·2015
Abstract A07: Combining CTLA4 and PD-L1 blockade leads to complete eradication of metastatic osteosarcoma
Cancer Immunology Research·2015· 2 cited
Abstract 1344: The ketogenic diet enhances immunity in a mouse model of malignant glioma
Cancer Research·2015
Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
Journal for ImmunoTherapy of Cancer·2015· 195 citedOpen Access
Enhanced T-Cell Immunity to Osteosarcoma Through Antibody Blockade of PD-1/PD-L1 Interactions
Journal of Immunotherapy·2015· 188 citedOpen Access
Increasing T Cell Immunity to Metastatic Osteosarcoma via Modulation of Inhibitory T Cell Receptors
2015
NCI meeting: Enhancement of T cell immunity to osteosarcoma through modulation of PD-1/PD-L1 interactions
2014Open Access
Enhancement of T cell immunity to osteosarcoma through modulation of PD-1/PD-L1 interactions
Journal for ImmunoTherapy of Cancer·2013· 2 citedOpen Access
Using the lymphocytic choriomeningitis virus mouse model of infection to link specific immune responses with epidemiological outcomes (P6318)
The Journal of Immunology·2013

Frequent Co-authors

Joseph N. Blattman(12), Robert D. Schreiber(6), John L. Johnson(6), Pooja Hingorani(6), Elise Alspach(4), Lizbeth M. Nieves(4), Megan S. McAfee(4), Susan Holechek(4), Alexander P. Miceli(3), Daniele Runci(3), Jeffrey P. Ward(3), Cora D. Arthur(3), J. Michael White(3), Tyler Jacks(3), Maxim N. Artyomov(3), Eric C. Woolf(3), Adrienne C. Scheck(3), Nicole Appel(3), Ilya Kizhvatov(2), Michel DuPage(2)